Physician profile
Patrick J Reardon
NPI 1275996183
$27,001.38
in general payments reported to CMS, 2019-2025
10 companies · $1,376 in 2025
The $1,376 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,780 · 2022: $15K · 2023: $2,943 · 2024: $4,386 · 2025: $1,376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,371 · Food and Beverage: $3,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,370.61 |
| Food and Beverage | $3,334.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $9,364.79 | 2022-2025 | Arthrex |
| Elite Orthopedics, LLC | $7,898.47 | 2022-2025 | |
| Smith+Nephew, INC. | $7,754.95 | 2021-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Whipknot, Spatial Frame |
| Vericel Corporation | $1,135.09 | 2023 | Maci |
| Stryker Corporation | $524.67 | 2022-2025 | Mako, Aequalis Ascend Flex, Alphavent |
| Zimmer Biomet Holdings, INC. | $159.53 | 2023 | Comprehensive Shoulder System, Identity, Rosa |
| Depuy Synthes Sales INC. | $114.59 | 2022 | |
| Medacta USA, INC. | $21.62 | 2024 | |
| Ethicon US, LLC | $14.25 | 2024 | Stratafix, Vistaseal |
| Deroyal Industries, INC. | $13.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Reardon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.